[ad_1]
(Reuters) – Canadian drugmaker Valeant Pharmaceuticals International Inc said the U.S. Food and Drug Administration approved Lumify drop to treat eye redness.
The eye drop, made by the company’s Bausch & Lomb eye care business, has been approved for over-the-counter sale, Valeant said.
Lumify, first approved in 1996 as a treatment for patients with glaucoma, is currently available at higher doses as a prescription medicine.
Reporting by Tamara Mathias in Bengaluru; Editing by Sriraj Kalluvila
Our Standards:The Thomson Reuters Trust Principles.
[ad_2]
